ReviewChembiochem : a European journal of chemical biology2026
Encoding Cell-Surface Receptor Function Through Glycosylation: Lessons From CD44.
Review in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cell surface receptors are traditionally conceptualized as discrete molecular entities whose functional diversity arises primarily from gene expression and protein sequence variation. However, this view overlooks the extensive heterogeneity generated by post-translational modifications, particularly glycosylation, which can profoundly alter receptor structure, dynamics, and interactions. Increasing evidence suggests that glycosylation does not simply fine-tune receptor activity but rather defines distinct functional receptor states by modulating ligand recognition, nanoscale organization, interaction networks, and signaling competence. Among glycosylated receptors, CD44 provides a particularly informative model due to its extensive alternative splicing, dense glycosylation, and well-characterized interactions with the extracellular matrix. CD44 exhibits remarkable structural and functional plasticity and regulates diverse biological processes ranging from cell adhesion and migration to inflammation and cancer progression. Importantly, glycosylation influences CD44 interactions with its principal ligand, hyaluronan, as well as its ability to cluster, engage coreceptors, and initiate downstream signaling pathways. In this review, we discuss how glycosylation regulates CD44 function across multiple levels, from molecular recognition to membrane organization and signaling. Using CD44 as a paradigmatic example, we explore how glycosylation may shape distinct aspects of receptor function, underscoring its importance as a fundamental determinant of receptor biology and its relevance for therapeutic targeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.